Affiliations 

  • 1 Health and Safety Department, Dubai Municipality, Dubai, UAE
  • 2 Clinical Pharmacy Program, College of Pharmacy, Al Ain University, Al Ain, UAE
  • 3 Artificial Intelligence Research Center, Al Ain University, Al Ain, UAE
  • 4 Discipline of Clinical Pharmacy, School of Pharmaceutical Sciences, Universiti Sains Malaysia (USM), George Town, Malaysia
  • 5 Centre of Medical and Bio-allied Health Sciences Research, Ajman University, Ajman, UAE
  • 6 Department of Mathematics and Sciences, Ajman University, Ajman, UAE
  • 7 Department of Biopharmaceutics and Clinical Pharmacy, Faculty of Pharmacy, The University of Jordan, Amman, Jordan
  • 8 Department of Pharmacy, School of Applied Sciences, University of Huddersfield, Huddersfield, UK
J Pharm Policy Pract, 2024;17(1):2303759.
PMID: 38229951 DOI: 10.1080/20523211.2024.2303759

Abstract

Generative AI can be a powerful research tool, but researchers must employ it ethically and transparently. This commentary addresses how the editors of pharmacy practice journals can identify manuscripts generated by generative AI and AI-assisted technologies. Editors and reviewers must stay well-informed about developments in AI technologies to effectively recognise AI-written papers. Editors should safeguard the reliability of journal publishing and sustain industry standards for pharmacy practice by implementing the crucial strategies outlined in this editorial. Although obstacles, including ignorance, time constraints, and protean AI strategies, might hinder detection efforts, several facilitators can help overcome those obstacles. Pharmacy practice journal editors and reviewers would benefit from educational programmes, collaborations with AI experts, and sophisticated plagiarism-detection techniques geared toward accurately identifying AI-generated text. Academics and practitioners can further uphold the integrity of published research through transparent reporting and ethical standards. Pharmacy practice journal staffs can sustain academic rigour and guarantee the validity of scholarly work by recognising and addressing the relevant barriers and utilising the proper enablers. Navigating the changing world of AI-generated content and preserving standards of excellence in pharmaceutical research and practice requires a proactive strategy of constant learning and community participation.

* Title and MeSH Headings from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.